Comparative Pharmacology
Head-to-head clinical analysis: LOVASTATIN versus ZYPITAMAG.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LOVASTATIN versus ZYPITAMAG.
LOVASTATIN vs ZYPITAMAG
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Reduces hepatic cholesterol synthesis, leading to increased LDL receptor expression and enhanced clearance of LDL from plasma.
ZYPITAMAG (pitavastatin magnesium) is a competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to reduced intracellular cholesterol and upregulation of LDL receptors.
10-80 mg orally once daily in the evening, starting at 10-20 mg once daily; maximum dose 80 mg/day.
2-4 mg orally once daily, at any time of day, with or without food.
None Documented
None Documented
Terminal elimination half-life: 1.5–2 hours for lovastatin acid; clinical context: short half-life supports evening dosing to maximize HMG-CoA reductase inhibition during peak cholesterol synthesis.
Clinical Note
moderateLovastatin + Levofloxacin
"The serum concentration of Levofloxacin can be increased when it is combined with Lovastatin."
Clinical Note
moderateLovastatin + Norfloxacin
"The serum concentration of Norfloxacin can be increased when it is combined with Lovastatin."
Clinical Note
moderateLovastatin + Resveratrol
"The serum concentration of Resveratrol can be increased when it is combined with Lovastatin."
Clinical Note
moderateLovastatin + Betamethasone
Terminal elimination half-life: 12 hours (range 10-14 h) in healthy subjects; supports once-daily dosing
Renal: 10% (as metabolites); Fecal: 83% (primarily as metabolites); Biliary: minor; <5% excreted unchanged in urine.
Primarily renal (93% as unchanged pitavastatin and metabolites) via active tubular secretion; fecal (5%)
Category D/X
Category C
Statin
Statin
"The serum concentration of Betamethasone can be increased when it is combined with Lovastatin."